Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Xili Technology

Request full access

A research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human…

South San Francisco, United StatesFounded 2021Biotech & Life Sciences

About Xili Technology

ReviR Therapeutics, also known as Xili Technology, is a drug discovery company that leverages ribonucleic acid (RNA) and artificial intelligence (AI) to create new medicines. The company has developed the VoyageR AI platform, which is a machine learning system used for identifying and validating RNA drug targets. This platform is also capable of designing drugs and predicting their effectiveness.

ReviR's primary focus is on developing treatments for genetic diseases that currently have few or no therapeutic options. The company utilizes its SpliceR modulation technologies to target specific RNAs associated with these diseases. In addition to its work on genetic disorders, ReviR is also exploring applications in oncology, as evidenced by its research collaboration with Asieris Pharmaceuticals.

The company's business model appears to be centered on both internal drug development and strategic partnerships with other pharmaceutical companies. By combining computational biology with high-throughput drug discovery techniques, ReviR aims to accelerate the development of next-generation therapies for patients.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
South San Francisco, United States
Employees
21
Open positions
None listed
Dealroom signal
71.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Core AI, Spinout, Biotech and Pharma, AI Drug Discovery, AI Applications, DT and LS, science-based
Technology
Artificial Intelligence, Machine Learning
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Apr 2026 $0 — CureCMT ↗
GRANTOther financing Nov 2025 $4.6M — California Institute for Regenerative Medicine ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Xili Technology website traffic

Latest recorded traffic for Xili Technology is 5K monthly website visits, up 354.5% over the last three months. Xili Technology's team grew 5% over the past year.

Latest monthly visits5K 3-month web change+354.5% 1-year team growth+5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Xili Technology in the South San Francisco ecosystem

Live from Dealroom

The Xili Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

Series A4 investors entered at this stage

  • CMT Research Foundation
  • Longpan Investment
  • XtalPi
  • Yayi Capital

Other known investors1 additional known investor

  • Thomas Jefferson University
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States80%
🇨🇳 China20%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Xili Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xili Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.